Transaktionen anzeigen
Healthcare

ERBC (ex CERB) has acquired RTC

The European Research Biology Center (ERBC) has acquired the Research Toxicology Center (RTC).

ERBC provides healthcare and chemical professionals a comprehensive range of experimental capabilities and services, from preclinical proof-of-concept to market of any type of drug candidate or chemical compound. Each project is managed by a study director, relying on a multi-disciplinary team of experts, notably in general pharmacology, cardiology, electrophysiology and pathophysiology, and also benefiting from a world-class academic and private network.

RTC is a fully fledged contract research laboratory located near Rome, Italy, with a track record spanning more than four decades. RTC collaborates with a large range of industrial clients including the pharmaceutical, biotech, chemical, agro-chemical and biocide industries.

Oaklins' team in France advised the buyer in this transaction.

Art der transaktion
Unternehmenskauf
BETEILIGTE PARTEIEN
“With the help of Oaklins, we are thrilled to join forces and offer a critical mass of credible and efficient alternative to the big CROs. We are proud to be a unique European player in the field. Our partnerships with the pharma, other CROs and independent experts play a key role in driving improvements in the pharmaceutical and chemical industries, delivering better data to regulators as well as improved value to study sponsors. Oaklins' team gave us fantastic support in a complex transaction.

Serge Richard

CEO, ERBC

Sprechen Sie mit dem Deal-Team

 Jean-Paul  Ortelli

Jean-Paul Ortelli

Senior Advisor

Paris, Frankreich
Oaklins France

Transaktionen

GeneTech Inc. has been acquired by Eurofins
Healthcare

GeneTech Inc. has been acquired by Eurofins

Noritsu Koki Co., Ltd. has sold GeneTech Inc. to Eurofins Clinical Testing Holding Lux S.à r.l.

Mehr erfahren
MediCa group has been acquired by Repharm
Healthcare

MediCa group has been acquired by Repharm

CGP Management has sold MediCa group, the largest private provider of healthcare services in Lithuania, to Repharm.

Mehr erfahren
The MOLE Clinic Limited has been acquired by Sk:n (backed by TriSpan)
Private Equity | Healthcare

The MOLE Clinic Limited has been acquired by Sk:n (backed by TriSpan)

The shareholders of The MOLE Clinic Limited have sold the company to Sk:n.

Mehr erfahren